<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04278014</url>
  </required_header>
  <id_info>
    <org_study_id>UdeA1006</org_study_id>
    <nct_id>NCT04278014</nct_id>
  </id_info>
  <brief_title>Continuous Sciatic Block Nerve in the Management of Vascular Pain in Critical Ischemia of Lower Limbs Patients</brief_title>
  <official_title>Evaluation of Ultrasound Guided Continuous Sciatic Block Nerve With a Longitudinal Approach in the Management of Vascular Pain in Critical Ischemia of Lower Limbs Patients : Prospective Descriptive Study of Exploratory Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Antioquia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad de Antioquia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Critical limb ischemia (CLI) is associated with severe pain that is a therapeutic challenge&#xD;
      whit therapeutic limits for the use of conventional analgesics medications. ultrasound-guided&#xD;
      continuous sciatic block (CCBN) is strategy effective and safe to consider in this patients.&#xD;
&#xD;
      This prospective descriptive exploratory cohort study evaluates CCBN as a effective&#xD;
      therapeutic tools for patients whit (CLI)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Critical limb ischemia is the final stage of peripheral vascular disease identified by&#xD;
      resting pain greater than 2 weeks with ulcers or gangrene in 1 or both extremities. Pain&#xD;
      relief is a therapeutic challenge due to its severity, which significantly affects the&#xD;
      quality of life, and the comorbidities that occur frequently in these patients, which limits&#xD;
      the use of analgesics medications. Regional techniques can play an important role as they are&#xD;
      safe and effective in analgesic management . Within these we find the ultrasound guided&#xD;
      continuous sciatic block as a strategy to consider in the periods of exacerbation of pain, as&#xD;
      a bridge to a palliative or resolutive management.&#xD;
&#xD;
      Prospective descriptive exploratory cohort study.&#xD;
&#xD;
      Patients with a diagnosis of critical ischemia of the lower limb with severe pain and side&#xD;
      effects of opioids will be included. A continuous ultrasound-guided sciatic nerve block with&#xD;
      longitudinal approach will be performed, with no anti-aggregation or anticoagulation&#xD;
      suspension, continuing with an infusion of Bupivacaine 0.1%&#xD;
&#xD;
      The primary outcome will be numerical pain rating scale (NPrs) and secondary outcome Pinprick&#xD;
      test, catheter duration, opioid consumption reduction and side effects to it.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Actual">February 1, 2021</completion_date>
  <primary_completion_date type="Actual">February 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Days</target_duration>
  <primary_outcome>
    <measure>Pain level measurement with Numeric Rate Score (NRS)</measure>
    <time_frame>5 days</time_frame>
    <description>0-10 where 0 means no pain and 10 means maximum possible pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pinprick test</measure>
    <time_frame>5 days</time_frame>
    <description>evaluation of superficial sensitivity in S1 dermatome positive or negative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>catheter duration</measure>
    <time_frame>5 days</time_frame>
    <description>number of days in which the catheter is functional</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>opioid consumption reduction</measure>
    <time_frame>5 days</time_frame>
    <description>opioid consumption in morphine equivalence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium</measure>
    <time_frame>5 days</time_frame>
    <description>minimental test score from 0 to 30 points. Delirium positive for less than 24</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nauseas and Vomit</measure>
    <time_frame>5 days</time_frame>
    <description>yes or not present</description>
  </secondary_outcome>
  <enrollment type="Actual">13</enrollment>
  <condition>Critical Limb Ischemia</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ultrasound-guided continuous sciatic block with longitudinal approach</intervention_name>
    <description>ultrasound-guided continuous sciatic block with longitudinal approach</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a diagnosis of critical ischemia of the lower limb with severe pain and side&#xD;
        effects of opioids over 18 years old who accept the interventional technique&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with a diagnosis of critical ischemia of the lower limb with severe pain and&#xD;
             side effects of opioids&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under 18 years old&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>hospital universitario San Vicente Fundacion</name>
      <address>
        <city>Medellin</city>
        <state>Antioquia</state>
        <zip>0057</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Adriana Cadavid, MD</name>
      <address>
        <city>Medell√≠n</city>
        <state>Antiquia</state>
        <zip>050010</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 18, 2020</study_first_submitted>
  <study_first_submitted_qc>February 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2020</study_first_posted>
  <last_update_submitted>April 30, 2021</last_update_submitted>
  <last_update_submitted_qc>April 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

